JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells

Wei Xu(Jiangsu Province Hospital), Jianwei Zhou(Second Affiliated Hospital of Zhejiang University)

Cell Death and Disease

December 4, 2014

10.1038/cddis.2014.517

Cited by 58

Related Papers

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|390

JAK2-binding long noncoding RNA promotes breast cancer brain metastasis

|Journal of Clinical Investigation|2017|231

TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer

|Cell Death and Disease|2014|84

JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis

|Journal of Experimental & Clinical Cancer Research|2020|55

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

|Cell & Bioscience|2015|50